Navigation Links
Also in the May 27 JNCI
Date:5/27/2008

d better disease-free survival compared with patients treated with standard therapy alone, according to the final results from a randomized phase III trial.

Paclitaxel and other taxanes are among the most active agents in metastatic breast cancer. Researchers are now testing the drugs in patients with early, non-metastatic breast cancer.

In the current study, Miguel Martn, M.D., of the Spanish Breast Cancer Research Group and colleagues randomly assigned 1,246 women to treatment with fluorouracil, epirubicin, and cyclophosphamide (FEC) or FEC followed by weekly paclitaxel (FEC-P).

The estimated 5-year survival rate was 78.5 percent in the FEC-P arm and 72.1 percent in the FEC arm. There was a trend toward improved overall survival, but it did not reach statistical significance. Because distant relapse-free survival is usually associated with overall survival, a statistically significant benefit in overall survival may become evident with a more protracted follow-up, the authors write.

A retrospective analysis of the data failed to detect a subgroup of patients who were more likely to respond to taxane therapy on the basis of their tumors expression of the estrogen receptor and HER2.

In an accompanying editorial, Clifford Hudis, M.D., and Chau Dang, M.D., of Memorial Sloan-Kettering Cancer Center in New York review several trials that tested the potential benefit of adding taxanes to existing adjuvant therapy. From that point of view, the study by Martn and colleagues is important because it is well designed and uses a good regimen and schedule of drugs.

They emphasize that retrospective analyses should be considered hypothesis generating only, particularly when the results from several similar analyses are inconsistent If you accept that the taxanes are effective, hormone receptor and HER2 status should not routinely guide your selection of patients for this therapy, the editorialists conclude.

Conta
'/>"/>

Contact: Liz Savage
jncimedia@oxfordjournals.org
301-841-1287
Journal of the National Cancer Institute
Source:Eurekalert

Page: 1 2 3 4

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/30/2015)... 2015 At 73 years old, Lynn ... health , which she attributes to a lifetime of being ... nutrition with the release of her new book titled “ ... , “Cook for Health and Longevity” features a collection of ... organic food . It is designed to encourage a ...
(Date:5/30/2015)... MA (PRWEB) May 30, 2015 ... bike tour, “Wheels for the World 2015: Piles ... 30 to raise awareness about hemophilia and encourage ... One Life. , Save One Life supports ... in eleven developing countries through direct sponsorships, scholarships ...
(Date:5/30/2015)... 2015 San Luis Obispo insurance ... offering a free analysis and consultation for anyone interested ... Disability Awareness Month, which was created by the non-profit ... United States such as Polk recognize the proclamation, and ... the possibility of disability, as well as the often-overlooked ...
(Date:5/30/2015)... 30, 2015 The iconic American actor, ... be hosting a new segment on Medical Malpractice. This ... medical malpractice in the health care field. , According ... of medical malpractice suits were filed, roughly only 20% ... settled out of court, while the remaining 30% were ...
(Date:5/30/2015)... (PRWEB) May 30, 2015 “ Milli the ... monthly AppWatch, which takes a look at the latest and ... Joe Toohey, the host of AppWatch and technology expert, conducted ... an aesthetic game that engages and educates children. , Interactive ... Unfortunately not all the content and games they are playing ...
Breaking Medicine News(10 mins):Health News:Lynn Kendall Shows How to ‘Cook for Health and Longevity’ 2Health News:Lynn Kendall Shows How to ‘Cook for Health and Longevity’ 3Health News:Barry Haarde Cycles 4,000 Miles Across the USA for Hemophilia 2Health News:San Luis Obispo Insurance Agent Susan Polk Offering Complementary Insurance Analysis In Honor Of Disability Awareness Month 2Health News:An Aesthetic Game that Engages and Educates Children was Featured on NewsWatch Television 2
... six percent of children in the U.S. suffering from food ... aren,t always confident they have the ability to diagnose or ... the January 2010 issue of Pediatrics and headed ... Memorial Hospital and Assistant Professor of Pediatrics at Northwestern University,s ...
... more nutritious breakfast food , WEDNESDAY, Dec. 9 (HealthDay News) ... further cut the amount of sugar in the cereals it ... maker of such cereals as Lucky Charms and Cocoa Puffs, ... 10 of its products to less than 11 grams, following ...
... The Newly ... service , ... (PRWEB) December 9, 2009 -- Today, Syclo , a market leader in mobile enterprise ... relationship with SAP AG. The new product, SMART Service Manager , was recently selected ...
... , , , ... an educational Webinar featuring a discussion with leading microRNA scientists: ... M.D., Ph.D. Professor at the Swiss Federal Institute of Technology. ... role as a master regulator of the genome, and Dr. ...
... , NCCN updates the NCCN ... maintenance therapy, several new therapeutic recommendations for specific patients with ... FORT WASHINGTON, Pa., Dec. 9 The National Comprehensive ... Non-Small Cell Lung Cancer (NSCLC) to incorporate a new section ...
... variations in the Sonic Hedgehog pathway increase the ... response to therapy for people with non-muscle invasive ... M. D. Anderson Cancer Center reported today at ... Cancer Prevention Research Conference. "These variations are ...
Cached Medicine News:Health News:Physicians knowledge of childhood food allergies needs room for improvement 2Health News:General Mills to Cut Sugar in Kids' Cereals 2Health News:Syclo Mobile Field Service Product, Resulting from Co-innovation with SAP, Selected by Medical System Supplier 2Health News:Syclo Mobile Field Service Product, Resulting from Co-innovation with SAP, Selected by Medical System Supplier 3Health News:Syclo Mobile Field Service Product, Resulting from Co-innovation with SAP, Selected by Medical System Supplier 4Health News:Webcast Alert: MicroRNA: The Year in Review 2Health News:NCCN Guidelines for Non-Small Cell Lung Cancer Updated to Incorporate Maintenance Therapy 2Health News:NCCN Guidelines for Non-Small Cell Lung Cancer Updated to Incorporate Maintenance Therapy 3Health News:Sonic Hedgehog variations linked to recurrence, survival and response to therapy of bladder cancer 2
(Date:5/29/2015)... SAN DIEGO and BOSTON ... a leader in instrument development, custom automation, and contract ... developer of the Nanopatch™ needle-free drug delivery technology, have ... for development of the Nanopatch Jet Coating Instrument ... drug delivery research and product development.  The award was ...
(Date:5/29/2015)... , May 29, 2015  Haemonetics Corporation (NYSE: ... Chief Operating Officer, will present at the JMP Securities ... on June 23 rd , 2015 at 11:30am ... Mr. Davies, presentation live via webcast at: http://wsw.com/webcast/jmp27/hae ... HAE ) is a global healthcare company dedicated ...
(Date:5/29/2015)... , May 29, 2015  Eli Lilly and Company ... ) today announced that they have entered into a ... efficacy of AstraZeneca,s investigational anti-PD-L1 immune checkpoint inhibitor, MEDI4736, ... Receptor 2 antiangiogenic cancer medicine. The planned study will ... advanced solid tumors. The Phase I study ...
Breaking Medicine Technology:Invetech And Vaxxas Named Recipients Of The 2015 Good Design Award For Development Of Nanopatch Jet Coating Instrument For Needle-Free Drug Delivery 2Invetech And Vaxxas Named Recipients Of The 2015 Good Design Award For Development Of Nanopatch Jet Coating Instrument For Needle-Free Drug Delivery 3Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 2Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 3Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 4Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 5Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 6Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 7Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 8Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 9Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 10Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 11Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 12Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 13Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 14
... CALGARY, Alberta, July 13, 2011 Fero Industries, ... report that Merck S.A. de C.V. has successfully ... points-of-sale to over 2,500 outlets and pharmacy chains. ... well-known retailers including WalMart Supercenters, Superama, Farmacias del ...
... Schein, Inc. (NASDAQ: HSIC ), the largest provider ... the Henry Schein Cares Foundation, Inc., announced today a contribution ... help provide health care to those who have been affected ... earthquake in New Zealand, and tornadoes in the United States. ...
Cached Medicine Technology:Fero Industries Expands Sucanon® Distribution in Mexico 2Fero Industries Expands Sucanon® Distribution in Mexico 3Henry Schein Cares Foundation and Henry Schein Cares Contribute More Than $375,000 in Financial and Product Donations for Disaster Relief Efforts on Three Continents 2Henry Schein Cares Foundation and Henry Schein Cares Contribute More Than $375,000 in Financial and Product Donations for Disaster Relief Efforts on Three Continents 3
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: